| Ian C Fyfe, MD | |
|
225 N 7th St, Bismarck, ND 58501-4417 | |
| (701) 323-6000 | |
| (701) 323-5823 |
| Full Name | Ian C Fyfe |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 37 Years |
| Location | 225 N 7th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144240532 | NPI | - | NPPES |
| 10971 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 8130 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Bismarck | 9739098575 | 448 |
News Archive
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
Weight discrimination is a major issue in our society and in the U.S. military, service members are not immune to it. According to a new study published Sept. 26 in the APA journal, Stigma and Health, nearly 50 percent of service members who are overweight or obese have experienced it.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
Increasing access to mental health services improves HIV outcomes among vulnerable patients, a new study from the University of Virginia School of Medicine suggests.
Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.
› Verified 5 days ago
| Entity Name | Sanford Bismarck |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811941172 PECOS PAC ID: 9739098575 Enrollment ID: O20031105000403 |
News Archive
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
Weight discrimination is a major issue in our society and in the U.S. military, service members are not immune to it. According to a new study published Sept. 26 in the APA journal, Stigma and Health, nearly 50 percent of service members who are overweight or obese have experienced it.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
Increasing access to mental health services improves HIV outcomes among vulnerable patients, a new study from the University of Virginia School of Medicine suggests.
Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.
› Verified 5 days ago
| Entity Name | Sanford Bismarck |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1598185597 PECOS PAC ID: 9739098575 Enrollment ID: O20040304000249 |
News Archive
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
Weight discrimination is a major issue in our society and in the U.S. military, service members are not immune to it. According to a new study published Sept. 26 in the APA journal, Stigma and Health, nearly 50 percent of service members who are overweight or obese have experienced it.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
Increasing access to mental health services improves HIV outcomes among vulnerable patients, a new study from the University of Virginia School of Medicine suggests.
Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ian C Fyfe, MD Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Ian C Fyfe, MD 225 N 7th St, Bismarck, ND 58501-4417 Ph: (701) 323-6000 |
News Archive
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
Weight discrimination is a major issue in our society and in the U.S. military, service members are not immune to it. According to a new study published Sept. 26 in the APA journal, Stigma and Health, nearly 50 percent of service members who are overweight or obese have experienced it.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
Increasing access to mental health services improves HIV outcomes among vulnerable patients, a new study from the University of Virginia School of Medicine suggests.
Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.
› Verified 5 days ago
Dr. Joseph W Carlson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 310 N 9th St, Bismarck, ND 58501 Phone: 701-530-8800 Fax: 701-530-8763 | |
Dr. Timothy J Bopp, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 310 N 9th St, Bismarck, ND 58501 Phone: 701-530-8800 Fax: 701-583-0876 | |
Dr. Timothy J Juelson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 310 N 9th St, Bismarck, ND 58501 Phone: 701-530-8800 Fax: 701-751-4550 | |
Coridon Michael Huez, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-8920 Fax: 701-323-5849 | |
William D Canham, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5823 | |
Anthony Robert Kasch, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-8920 |